What is the recommended treatment for shingles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Shingles (Herpes Zoster)

Start oral antiviral therapy with valacyclovir 1 gram three times daily for 7 days, ideally within 48-72 hours of rash onset, for all immunocompetent patients over 50 years of age and those with head/neck involvement at any age. 1

Antiviral Therapy

Standard Treatment for Immunocompetent Patients

  • Valacyclovir 1 gram three times daily for 7 days is the recommended regimen, initiated at the earliest sign or symptom of herpes zoster and most effective when started within 48 hours of rash onset 1
  • Alternative dosing of valacyclovir 1.5 grams twice daily has demonstrated equivalent safety and efficacy, with the advantage of improved compliance due to simpler dosing 2
  • Treatment can be given without regard to meals 1

Timing of Initiation

  • Antiviral therapy should ideally be started within 48-72 hours of rash onset for maximum effectiveness 3, 4
  • However, treatment initiated beyond 72 hours may still provide benefit for reducing zoster-associated pain duration, so do not withhold therapy in late presenters 5

Immunocompromised Patients

  • For immunocompromised patients with severe disease or complications, use intravenous acyclovir 5-10 mg/kg every 8 hours 6, 7
  • Continue IV therapy until clinical resolution is achieved, which may require prolonged treatment duration beyond the standard 7 days 7

Specific Indications for Antiviral Treatment

Urgent Indications (Must Treat)

  • All patients ≥50 years of age regardless of location 4
  • Herpes zoster in the head and neck area at any age, especially zoster ophthalmicus 4
  • Severe herpes zoster on trunk or extremities 4
  • All immunosuppressed patients 4
  • Patients with severe atopic dermatitis or eczema 4

Relative Indications

  • Patients <50 years with zoster on trunk or extremities have only relative indications for treatment 4

Pain Management

Acute Pain Control

  • Combine appropriately dosed analgesics with a neuroactive agent (such as amitriptyline) alongside antiviral therapy 4
  • Narcotics may be required for adequate pain control in patients with postherpetic neuralgia 3

Adjunctive Corticosteroids

  • Oral corticosteroids may provide modest benefits in reducing acute zoster pain but have no essential effect on preventing postherpetic neuralgia 3, 4

Postherpetic Neuralgia Management

  • Tricyclic antidepressants or anticonvulsants in low dosages help control neuropathic pain 3
  • Capsaicin cream, lidocaine patches, and nerve blocks can be used in selected patients 3
  • Early referral to a pain specialist is recommended for difficult cases 4

Special Considerations

Ocular Involvement

  • Herpes zoster ophthalmicus can lead to serious complications and generally merits referral to an ophthalmologist 3

Infection Control

  • Advise patients that lesions are contagious to individuals who have not had chickenpox 6
  • Patients should avoid contact with susceptible individuals until all lesions have crusted over 7

Common Pitfalls to Avoid

  • Do not withhold treatment in patients presenting after 72 hours, as they may still benefit from antiviral therapy 5
  • Antiviral medications are generally well-tolerated, with common side effects including nausea, headache, and gastrointestinal disturbances 6
  • In observational studies, only 50% of high-risk patients received appropriate antiviral therapy, mainly due to late presentation beyond 72 hours—this represents suboptimal care 8

References

Research

Herpes zoster guideline of the German Dermatology Society (DDG).

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003

Guideline

Antiviral Therapy and Patient Management for Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Herpes Zoster Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.